185 related articles for article (PubMed ID: 12235123)
21. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
Izeradjene K; Douglas L; Delaney AB; Houghton JA
Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
Chawla-Sarkar M; Bae SI; Reu FJ; Jacobs BS; Lindner DJ; Borden EC
Cell Death Differ; 2004 Aug; 11(8):915-23. PubMed ID: 15118763
[TBL] [Abstract][Full Text] [Related]
23. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
Aggarwal BB; Bhardwaj U; Takada Y
Vitam Horm; 2004; 67():453-83. PubMed ID: 15110190
[TBL] [Abstract][Full Text] [Related]
24. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
Ng CP; Zisman A; Bonavida B
Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
MacFarlane M; Harper N; Snowden RT; Dyer MJ; Barnett GA; Pringle JH; Cohen GM
Oncogene; 2002 Oct; 21(44):6809-18. PubMed ID: 12360407
[TBL] [Abstract][Full Text] [Related]
26. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
[TBL] [Abstract][Full Text] [Related]
27. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells.
Gilbert S; Loranger A; Marceau N
Mol Cell Biol; 2004 Aug; 24(16):7072-81. PubMed ID: 15282307
[TBL] [Abstract][Full Text] [Related]
28. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
29. TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase.
Neumeyer J; Hallas C; Merkel O; Winoto-Morbach S; Jakob M; Thon L; Adam D; Schneider-Brachert W; Schütze S
Exp Cell Res; 2006 Jul; 312(11):2142-53. PubMed ID: 16631736
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.
Nesterov A; Nikrad M; Johnson T; Kraft AS
Cancer Res; 2004 Jun; 64(11):3922-7. PubMed ID: 15173003
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
32. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A
Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760
[TBL] [Abstract][Full Text] [Related]
33. Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription.
Schickling O; Stegh AH; Byrd J; Peter ME
Cell Death Differ; 2001 Dec; 8(12):1157-68. PubMed ID: 11753564
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of DEDD2, a death effector domain-containing protein.
Roth W; Stenner-Liewen F; Pawlowski K; Godzik A; Reed JC
J Biol Chem; 2002 Mar; 277(9):7501-8. PubMed ID: 11741985
[TBL] [Abstract][Full Text] [Related]
35. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis.
Caulín C; Salvesen GS; Oshima RG
J Cell Biol; 1997 Sep; 138(6):1379-94. PubMed ID: 9298992
[TBL] [Abstract][Full Text] [Related]
36. Subcellular localization and CARD-dependent oligomerization of the death adaptor RAIDD.
Shearwin-Whyatt LM; Harvey NL; Kumar S
Cell Death Differ; 2000 Feb; 7(2):155-65. PubMed ID: 10713730
[TBL] [Abstract][Full Text] [Related]
37. Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis.
MacFarlane M; Merrison W; Dinsdale D; Cohen GM
J Cell Biol; 2000 Mar; 148(6):1239-54. PubMed ID: 10725337
[TBL] [Abstract][Full Text] [Related]
38. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.
Coleman ML; Sahai EA; Yeo M; Bosch M; Dewar A; Olson MF
Nat Cell Biol; 2001 Apr; 3(4):339-45. PubMed ID: 11283606
[TBL] [Abstract][Full Text] [Related]
39. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus.
Stegh AH; Schickling O; Ehret A; Scaffidi C; Peterhänsel C; Hofmann TG; Grummt I; Krammer PH; Peter ME
EMBO J; 1998 Oct; 17(20):5974-86. PubMed ID: 9774341
[TBL] [Abstract][Full Text] [Related]
40. Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis.
Xanthoudakis S; Roy S; Rasper D; Hennessey T; Aubin Y; Cassady R; Tawa P; Ruel R; Rosen A; Nicholson DW
EMBO J; 1999 Apr; 18(8):2049-56. PubMed ID: 10205159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
